Anzeige
Mehr »
Dienstag, 15.07.2025 - Börsentäglich über 12.000 News
Diese Aktie zeigt die wissenschaftliche Schlagkraft hinter ihrer KI-gesteuerten Krebsforschung
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
56 Leser
Artikel bewerten:
(0)

Elsevier Presents 20th Edition of Nelson Textbook of Pediatrics

PHILADELPHIA, June 10, 2015 /PRNewswire/ --

After more than 75 years, trusted resource continues to provide definitive, state-of-the-art answers on every aspect of pediatric care

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of the 20th edition of Nelson Textbook of Pediatrics. The 20th edition of Nelson Textbook of Pediatrics includes 35 new chapters on how to effectively apply the latest techniques and approaches to the practice of pediatric medicine. Also, a new rehabilitation section includes 10 chapters that help recognize, diagnose, and manage genetic and acquired conditions more effectively.

"Nelson Textbook of Pediatrics is the go-to reference guide for pediatric health and holds the most trusted answers in pediatrics for practicing physicians," said Robert Kliegman, MD, Senior Editor of Nelson Textbook of Pediatrics. "I personally make sure that the most recent information on diagnosis and treatment of pediatric diseases based on the latest recommendations and methodologies is included."

The field of pediatrics is growing worldwide, with new findings and treatments being developed every year. To keep up with all the new content and additional chapters, Nelson Textbook of Pediatrics for the first time has been expanded to two volumes.

For more than 75 years, Nelson Textbook of Pediatrics has been an indispensable source for definitive, state-of-the-art answers on every aspect of pediatric care. This classic reference provides the essential information that practitioners and other care providers involved in pediatric health care throughout the world need to understand to effectively address the range of biological, psychological, and social problems that children and youth may face. Those who purchase the new edition will receive the two-volume set as well as the Expert Consult eBook version, offering regularly updated content.

"Nelson Textbook of Pediatrics is known as the most trusted resource in pediatric care, making Elsevier a valuable and valued resource for pediatric physicians," said Linda Belfus, Senior Vice President of Content, Elsevier Clinical Solutions. "The material has been available for more than 75 years and the book's contributors effectively address every aspect of pediatric care as well as the latest advances in science."

Nelson Textbook of Pediatrics is currently available for order in print and eBook. The print copy of the book will include the Expert Consult eBook edition, which is compatible with PC, Mac and most mobile devices and eReaders, and allows readers to browse, search, and interact with the content of the book. To purchase the print version, go to us.elsevierhealth.com. To purchase the ebook version, or purchase individual chapters, go toexpertconsult.inkling.com.

---

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey - and publishes over 2,500 journals, including The Lancet and Cell, and more than 33,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group plc, a world-leading provider of information solutions for professional customers across industries. http://www.elsevier.com

Media contact
Christopher Capot
Director, Corporate Relations
Elsevier
+1-212-633-3164
c.capot@elsevier.com

© 2015 PR Newswire
Hensoldt, Renk & Rheinmetall teuer
Rheinmetall, Renk und Hensoldt haben den Rüstungsboom der letzten Jahre dominiert, doch inzwischen sind diese Titel fundamental heillos überbewertet. KGVs jenseits der 60, KUVs über 4, und das in einem politisch fragilen Umfeld mit wackelnder Haushaltsdisziplin. Für späteinsteigende Anleger kann das teuer werden.

Doch es gibt Alternativen, die bislang unter dem Radar fliegen; solide bewertet, operativ stark und mit Nachholpotenzial.

In unserem kostenlosen Report zeigen wir dir, welche 3 Rüstungsunternehmen noch Potenzial haben und wie du von der zweiten Welle der Zeitenwende profitieren kannst, ohne sich an überhitzten Highflyer zu verbrennen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders vom weltweiten Aufrüsten profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.